Unknown

Dataset Information

0

Consumption of Enriched Yogurt with PAF Inhibitors from Olive Pomace Affects the Major Enzymes of PAF Metabolism: A Randomized, Double Blind, Three Arm Trial.


ABSTRACT: Platelet-activating factor (PAF), a proinflammatory lipid mediator, plays a crucial role in the formation of the atherosclerotic plaque. Therefore, the inhibition of endothelium inflammation by nutraceuticals, such as PAF inhibitors, is a promising alternative for preventing cardiovascular diseases. The aim of the present study was to evaluate the impact of a new functional yogurt enriched with PAF inhibitors of natural origin from olive oil by-products on PAF metabolism. Ninety-two apparently healthy, but mainly overweight volunteers (35-65 years) were randomly allocated into three groups by block-randomization. The activities of PAF's biosynthetic and catabolic enzymes were measured, specifically two isoforms of acetyl-CoA:lyso-PAF acetyltransferase (LPCATs), cytidine 5'-diphospho-choline:1-alkyl-2-acetyl-sn-glycerol cholinephosphotransferase (PAF-CPT) and two isoforms of platelet activating factor acetylhydrolase in leucocytes (PAF-AH) and plasma (lipoprotein associated phospholipase-A2, LpPLA2). The intake of the enriched yogurt resulted in reduced PAF-CPT and LpPLA2 activities. No difference was observed in the activities of the two isoforms of lyso PAF-AT. In conclusion, intake of yogurt enriched in PAF inhibitors could favorably modulate PAF biosynthetic and catabolic pathways.

SUBMITTER: Detopoulou M 

PROVIDER: S-EPMC8227157 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4924185 | biostudies-literature
| S-EPMC9318848 | biostudies-literature
| S-EPMC7438237 | biostudies-literature
| S-EPMC5615154 | biostudies-literature
| S-EPMC6424929 | biostudies-literature
| S-EPMC7143744 | biostudies-literature
| S-EPMC7146296 | biostudies-literature
| S-EPMC9914016 | biostudies-literature
| S-EPMC8392337 | biostudies-literature
| S-EPMC8118642 | biostudies-literature